Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons
- 23 November 2014
- journal article
- review article
- Published by Springer Nature in Surgery Today
- Vol. 45 (11) , 1341-1351
Abstract
In 2011, a new pathological classification of lung adenocarcinoma was proposed by the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society. The new criteria classify adenocarcinomas into eight subtypes according to their histological features. The criteria introduce a new concept of early stage lung cancer, consisting of adenocarcinoma in situ and minimally invasive adenocarcinoma, and categorize invasive adenocarcinomas by the predominant histological pattern. In addition to morphological differences among subtypes, the classification also considers the tumor behavior based on the genetic background within each subtype. We herein review the clinical impact of this new classification for chest surgeons based on the data from several recent validation studies from various institutions.Keywords
This publication has 69 references indexed in Scilit:
- Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.2014
- The evolving genomic classification of lung cancerThe Journal of Pathology, 2013
- A worldwide trend of increasing primary adenocarcinoma of the lungSurgery Today, 2013
- Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking doseLung Cancer, 2013
- Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classificationClinical Radiology, 2013
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyThe Lancet Oncology, 2012
- Overview and Strategic Management of Subsolid Pulmonary NodulesJournal of Thoracic Imaging, 2012
- Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classificationVirchows Archiv, 2012
- Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experienceThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resectionLung Cancer, 2004